SEARCH OUR PRODUCT CATALOG

NFASC-NTRK1 Fusion FISH Probe

The NFASC-NTRK1 Fusion FISH Probe is used to confirm a fusion of the NFASC and NTRK1 genes. The fusion of the NFASC and NTRK1 genes has been associated with Glioblastoma Multiforme. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
NFASC-NTRK1-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
NFASC-NTRK1-20-RERE 20 (40 μL) 200 μL
NFASC-NTRK1-20-REOR 20 (40 μL) 200 μL
NFASC-NTRK1-20-REGO 20 (40 μL) 200 μL
NFASC-NTRK1-20-REGR 20 (40 μL) 200 μL
NFASC-NTRK1-20-REAQ 20 (40 μL) 200 μL
NFASC-NTRK1-20-ORRE 20 (40 μL) 200 μL
NFASC-NTRK1-20-OROR 20 (40 μL) 200 μL
NFASC-NTRK1-20-ORGO 20 (40 μL) 200 μL
NFASC-NTRK1-20-ORAQ 20 (40 μL) 200 μL
NFASC-NTRK1-20-GORE 20 (40 μL) 200 μL
NFASC-NTRK1-20-GOOR 20 (40 μL) 200 μL
NFASC-NTRK1-20-GOGO 20 (40 μL) 200 μL
NFASC-NTRK1-20-GOGR 20 (40 μL) 200 μL
NFASC-NTRK1-20-GOAQ 20 (40 μL) 200 μL
NFASC-NTRK1-20-GRRE 20 (40 μL) 200 μL
NFASC-NTRK1-20-GROR 20 (40 μL) 200 μL
NFASC-NTRK1-20-GRGO 20 (40 μL) 200 μL
NFASC-NTRK1-20-GRGR 20 (40 μL) 200 μL
NFASC-NTRK1-20-GRAQ 20 (40 μL) 200 μL
NFASC-NTRK1-20-AQRE 20 (40 μL) 200 μL
NFASC-NTRK1-20-AQOR 20 (40 μL) 200 μL
NFASC-NTRK1-20-AQGO 20 (40 μL) 200 μL
NFASC-NTRK1-20-AQGR 20 (40 μL) 200 μL
NFASC-NTRK1-20-AQAQ 20 (40 μL) 200 μL

NTRK1 Gene Summary

This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]

Gene Name: Neurotrophic Receptor Tyrosine Kinase 1

Chromosome: CHR1: 156785541 -156851642

Locus: 1q23.1

NFASC Gene Summary

This gene encodes an L1 family immunoglobulin cell adhesion molecule with multiple IGcam and fibronectin domains. The protein functions in neurite outgrowth, neurite fasciculation, and organization of the axon initial segment (AIS) and nodes of Ranvier on axons during early development. Both the AIS and nodes of Ranvier contain high densities of voltage-gated Na+ (Nav) channels which are clustered by interactions with cytoskeletal and scaffolding proteins including this protein, gliomedin, ankyrin 3 (ankyrin-G), and betaIV spectrin. This protein links the AIS extracellular matrix to the intracellular cytoskeleton. This gene undergoes extensive alternative splicing, and the full-length nature of some variants has not been determined.[provided by RefSeq, May 2009]

Gene Name: Neurofascin

Chromosome: CHR1: 204797781 -204991950

Locus: 1q32.1

Gene Diseases

The NFASC NTRK1 Fusion has been associated with the following diseases:

Disease Name
Glioblastoma Multiforme

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

TRKA expression and NTRK1 gene copy number across solid tumours

Our NTRK1 break apart probe was used to detect NTRK1 rearrangements in solid tumors from more than 1,000 patients. Over 14 different cancer types were analyzed, including lung, colorectal, and breast. NTRK1 translocations were identified in 5.9% of patients.

TRKA expression and NTRK1 gene copy number across solid tumours

Our NTRK1 break apart probe was used to detect NTRK1 rearrangements in solid tumors from more than 1,000 patients. Over 14 different cancer types were analyzed, including lung, colorectal, and breast. NTRK1 translocations were identified in 5.9% of patients.

Atypical Spitzoid Neoplasms in Childhood: A Molecular and Outcome Study

Atypical spitzoid neoplasms (APNs) are primarily pediatric lesions characterized by their intermediate features; clinically and histopathologically, they fall somewhere between benign spitz nevi and malignant melanoma. The genetics of these tumors are still poorly understood. In this study, 34 APNs were analyzed using FISH and IHC. Our ALK, BRAF, and NTRK1 break-apart FISH probes were used to detect rearrangements of the genes .

Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient

Our NTRK1 break apart probe helped to detect a new NTRK1 fusion in a 61 year old patient with adenocarcinoma of the right colon and pancreas. The team was able to verify that this novel fusion – SCYL3-NTRK1 – was in fact an oncogenic driver by transfecting cells with a SCYL3-NTRK1 cDNA construct, which lead to IL3-independent proliferation.